Page last updated: 2024-09-03

nitroaspirin and Sensitivity and Specificity

nitroaspirin has been researched along with Sensitivity and Specificity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bobko, A; Bratasz, A; Ignarro, LJ; Khramtsov, VV; Kuppusamy, P; Selvendiran, K; Wasowicz, T	1

Other Studies

1 other study(ies) available for nitroaspirin and Sensitivity and Specificity

Article	Year
NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols. Journal of translational medicine, 2008, Feb-26, Volume: 6 Topics: Animals; Antineoplastic Agents; Aspirin; Cell Line, Tumor; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Mice; Mice, Nude; Molecular Structure; Nitro Compounds; Ovarian Neoplasms; Sensitivity and Specificity; Statistics as Topic; Sulfhydryl Compounds; Xenograft Model Antitumor Assays	2008

Article

Year

NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.

Journal of translational medicine, 2008, Feb-26, Volume: 6

Topics: Animals; Antineoplastic Agents; Aspirin; Cell Line, Tumor; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Mice; Mice, Nude; Molecular Structure; Nitro Compounds; Ovarian Neoplasms; Sensitivity and Specificity; Statistics as Topic; Sulfhydryl Compounds; Xenograft Model Antitumor Assays

2008